CELL DEATH DIS 润色咨询

Cell Death & Disease

出版年份:2010 年文章数:6499 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2024-02-06 ms3000001660419742 来自台湾省

    偏重的研究方向:幹細胞
    经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2023-07-01 Shawnwang 来自广东省

    偏重的研究方向:细胞死亡
    经验分享:刚刚submit,上帝保佑,沾沾大家的喜气

    10

    展开10条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2024-03-05 超超不吵吵 来自湖南省

    投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2022-10-02 ms4000000661887175

    请问有投综述的吗?从提交文章到有结果大概是什么流程?

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2020-10-16 ms7000000270052196

    审稿速度:2.0 | 版面费用:3990.0
    偏重的研究方向:肿瘤;代谢
    经验分享:这里我将自己的投稿过程详细的分享给大家:
    2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;
    2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;
    2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;
    2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。
    整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。

    30

    展开30条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2023-03-02 ms5000001783815451 来自湖北省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤;机制研究
    经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!

    29

    展开29条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2023-03-13 1477c636m76(暂无昵称) 来自湖南省

    投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2023-11-22 ms3000000126427156 来自湖南省

    我已经112天了,一审还没回,等的好着急啊

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2023-01-06 ms8000000234756794 来自陕西省

    偏重的研究方向:cell death
    经验分享:元旦前投的,已经22天了,状态还是not assigned。

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2186209, encodeId=09e8218620984, content=偏重的研究方向:幹細胞<br>经验分享:1/11 投稿 還沒有editor assigned,祝大家投稿順利 來沾沾大家的喜氣QQ, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17858640518, createdName=ms3000001660419742, createdTime=Tue Feb 06 14:04:30 CST 2024, time=2024-02-06, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2145879, encodeId=116a21458e967, content=偏重的研究方向:细胞死亡<br>经验分享:刚刚submit,上帝保佑,沾沾大家的喜气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29a11951706, createdName=Shawnwang, createdTime=Sat Jul 01 23:23:58 CST 2023, time=2023-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2191210, encodeId=b2c02191210ea, content=投了一篇综述,一直是Under Consideration,在第22天左右分配了编辑,然后第5天出现了Reviewer Zip File "Zip of files for Reviewer" ,等待中。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Tue Mar 05 19:36:34 CST 2024, time=2024-03-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091499, encodeId=f7a4209149988, content=请问有投综述的吗?从提交文章到有结果大概是什么流程?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45516427528, createdName=ms4000000661887175, createdTime=Sun Oct 02 18:07:57 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892414, encodeId=dbfd89241445, content=审稿速度:2.0 | 版面费用:3990.0<br>偏重的研究方向:肿瘤;代谢<br>经验分享:这里我将自己的投稿过程详细的分享给大家:<br>2020.05.29 第一次提交投稿,7~10天左右分配编辑发邮件提示收到邮件;<br>2020.06.29 收到两位审稿专家的意见为大修,编辑给了两个月时间;<br>2020.08.24 二次提交修回稿件,由于缺少文件被退回,两天后重新提交;<br>2020.09.22 收到邮件通知官方接收,来来回回修改几次格式以后收取版面费校样,半个月左右online。<br>整个投稿过程比较顺利,审稿人提的意见比较中肯,看的也很仔细,大到文章的整体结构与思路,小到一个标点符号,所以我整整补了两个月的实验并且回复信写了将近20多页PDF,最终得到了审稿人的认可与鼓励。个人认为该杂志对文章创新性要求并不十分高,但是对数据量要求较高,另外版面费比较贵。所以数据多不差钱的小伙伴值得一试。希望可以给迷惘投稿的同行们带来一点讯息,以上仅为个人意见,请结合自身情况酌情参考。谢谢大家。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/92f08f156b054c6b86f0325ca8b1fdf9/8d711cf9a8f746219a67fdfeece251c2.jpg, createdBy=62ca5338422, createdName=ms7000000270052196, createdTime=Fri Oct 16 10:25:42 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117302, encodeId=0bf1211e30227, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;机制研究<br>经验分享:刚刚原则性接收,分享一下投稿历程 从投稿到送审:18天 一审(邀请3个2个同意):38天 返修:45天 二审:11天 (一定要认真回复审稿人的每个意见) 祝各位好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57c65696949, createdName=ms5000001783815451, createdTime=Thu Mar 02 23:22:52 CST 2023, time=2023-03-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2119214, encodeId=60ff2119214ec, content=投稿28天了,没有editor assigned,没有zip for reviewer,状态一直是under consideration,不知道该怎么办了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08835220748, createdName=1477c636m76(暂无昵称), createdTime=Mon Mar 13 15:34:06 CST 2023, time=2023-03-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2170123, encodeId=187121e012348, content=我已经112天了,一审还没回,等的好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63f08601112, createdName=ms3000000126427156, createdTime=Wed Nov 22 08:14:22 CST 2023, time=2023-11-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109176, encodeId=358821091e6b1, content=偏重的研究方向:cell death<br>经验分享:元旦前投的,已经22天了,状态还是not assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4378485487, createdName=ms8000000234756794, createdTime=Fri Jan 06 21:25:56 CST 2023, time=2023-01-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220134, encodeId=719d122013439, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:信号通路<br>经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2238145594, createdName=ms6000001510978619, createdTime=Mon May 16 21:56:32 CST 2022, time=2022-05-16, status=1, ipAttribution=)]
    2022-05-16 ms6000001510978619

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:信号通路
    经验分享:信号通路的综述,1.29投出去,3.3大修意见,4.14修回,5.3补小修,5.8修回,5.9编辑部给导师发了要改到3500词再上传,没给我邮箱发,然后我以为系统bug,直接再提交,5.11说原则上接收,5.14校对格式,删改词数上交,现在等最后结果。不知道原则上接收到正式接收要多久呢?

    6

    展开6条回复
共500条页码: 3/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分